Two Sigma Investments’s Aratana Therapeutics, Inc. PETX Stock Holding History

Two Sigma Investments’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-85,308	Closed	-$440K	–	3993
2019 Q2	$440K	Sell	85,308 -83,951	-50%	-$377K	﹤0.01%	2599
2019 Q1	$609K	Buy	169,259 +125,251	+285%	+$543K	﹤0.01%	2146
2018 Q4	$270K	Buy	44,008 +33,400	+315%	+$204K	﹤0.01%	2526
2018 Q3	$62K	Buy	+10,608	New	+$53K	﹤0.01%	3096
2018 Q2	–	Sell	-26,973	Closed	-$119K	–	3840
2018 Q1	$119K	Buy	+26,973	New	+$120K	﹤0.01%	3028
2016 Q4	–	Sell	-23,532	Closed	-$220K	–	3673
2016 Q3	$220K	Buy	+23,532	New	+$195K	﹤0.01%	2909

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Two Sigma Investments's PETX Position: Q3 2019 in Review

Two Sigma Investments sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 85,308 shares — an estimated $440K sold.

Two Sigma Investments first reported a position in PETX in Q3 2016 and held it in 6 quarters. The position peaked at $609K in Q1 2019. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

Two Sigma Investments reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Two Sigma Investments sold 85,308 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $440K.
Two Sigma Investments first reported a position in Aratana Therapeutics, Inc. in Q3 2016 and held it in 6 quarters.
Two Sigma Investments's Aratana Therapeutics, Inc. position peaked at $609K in Q1 2019.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Two Sigma Investments's 13F filing for Q3 2019, filed 14 Nov 2019.